Auditor Expectations for QMS Documentation & Hierarchy During FDA, EMA and MHRA Inspections


Published on 05/12/2025

Auditor Expectations for QMS Documentation & Hierarchy During FDA, EMA and MHRA Inspections

In the regulated industries of pharmaceuticals, biotechnology, and medical devices, a robust Quality Management System (QMS) is essential for compliance with regulatory standards such as those set by the FDA, EMA, and MHRA. This article serves as a step-by-step tutorial on the expectations surrounding QMS documentation and hierarchy, focusing on the critical components such as policies, Standard Operating Procedures (SOPs), Work Instructions (WIs), forms, and records. By understanding these elements, quality managers, regulatory affairs professionals, and compliance officers can ensure their organizations meet regulatory requirements and maintain high-quality standards.

Step 1: Understanding the QMS Framework

The first step in establishing a compliant QMS is to understand its framework. A QMS is a structured system that

documents processes, procedures, and responsibilities for achieving quality policies and objectives. The primary objective is to ensure consistent quality in products and services, thereby enhancing customer satisfaction.

Key documents in this phase include:

  • Quality Policy: A formal statement from management outlining the organization’s commitment to quality.
  • Quality Manual: A document that describes the QMS, including its scope, processes, and interactions.
  • Quality Objectives: Specific goals aligned with the quality policy that the organization aims to achieve.

Responsibilities in this phase typically fall on the Quality Manager, who must ensure that the QMS framework aligns with both internal policies and external regulations, such as ISO 13485 and FDA 21 CFR Part 820. Common inspection findings in this area often include inadequate documentation of the quality policy or lack of alignment between quality objectives and organizational goals.

See also  Designing Governance and Ownership for Effective Combined & Companion QMS for Medical Devices & Combination Products in the QMS

Step 2: Developing QMS Documentation

Once the framework is established, the next step is to develop comprehensive QMS documentation. This documentation serves as the backbone of the QMS and must be meticulously crafted to meet regulatory expectations.

Key documents include:

  • Standard Operating Procedures (SOPs): Detailed, written instructions to achieve uniformity in the performance of a specific function.
  • Work Instructions (WIs): Step-by-step guides that provide detailed instructions on how to perform specific tasks.
  • Forms and Records: Documents used to capture data and evidence of compliance, such as training records, audit reports, and deviation reports.

In this phase, the Quality Manager collaborates with various departments to ensure that the documentation is relevant and practical. It is crucial to involve cross-functional teams to capture all necessary information. Common findings during inspections include missing or outdated SOPs and inadequate training records, which can lead to non-compliance with FDA and ISO standards.

Step 3: Implementing the QMS Documentation

With documentation in place, the next step is implementation. This involves training staff on the new procedures and ensuring that everyone understands their roles and responsibilities within the QMS.

Key objectives during implementation include:

  • Ensuring that all employees are trained on the QMS documentation relevant to their roles.
  • Establishing a system for monitoring compliance with the QMS.
  • Creating a feedback loop for continuous improvement.

Training sessions should be documented, and attendance records maintained as part of the compliance evidence. The Quality Manager is typically responsible for overseeing this phase, ensuring that training is effective and that employees can demonstrate competency in their roles. Common inspection findings in this area often include inadequate training records and lack of employee understanding of their responsibilities under the QMS.

Step 4: Monitoring and Measuring QMS Performance

Monitoring and measuring the performance of the QMS is critical for identifying areas for improvement and ensuring ongoing compliance. This phase involves collecting data on various quality metrics and analyzing them to assess the effectiveness of the QMS.

See also  Using Risk-Based Thinking to Strengthen QMS Implementation Roadmaps for Startups & Scale in Your QMS

Key activities include:

  • Internal Audits: Regularly scheduled audits to evaluate the effectiveness of the QMS and identify non-conformities.
  • Management Reviews: Periodic reviews by management to assess the QMS performance and determine necessary improvements.
  • Corrective and Preventive Actions (CAPA): Processes for addressing non-conformities and preventing their recurrence.

The Quality Manager plays a pivotal role in this phase, ensuring that audits are conducted according to established schedules and that findings are addressed promptly. Common inspection findings include failure to conduct regular audits or inadequate follow-up on CAPA items, which can lead to significant compliance issues with regulatory bodies like the FDA and EMA.

Step 5: Continuous Improvement of the QMS

The final step in the QMS process is continuous improvement. A compliant QMS is not static; it must evolve based on feedback, audit findings, and changes in regulations or business processes.

Key strategies for continuous improvement include:

  • Regular Training Updates: Ensuring that training materials are updated to reflect changes in procedures or regulations.
  • Stakeholder Feedback: Actively seeking input from employees, customers, and other stakeholders to identify areas for improvement.
  • Benchmarking: Comparing QMS performance against industry standards or competitors to identify best practices.

The Quality Manager is responsible for fostering a culture of continuous improvement within the organization. Common inspection findings in this area often include a lack of documented evidence of improvement initiatives or failure to act on feedback from audits and reviews.

Conclusion

In conclusion, a well-structured QMS documentation and hierarchy is essential for compliance with FDA, EMA, and MHRA regulations. By following the steps outlined in this article, quality managers and compliance professionals can ensure that their organizations meet regulatory expectations and maintain high-quality standards. Regular audits, effective training, and a commitment to continuous improvement are key to achieving and sustaining compliance in the regulated industries.

See also  Vendor & Platform Comparisons: Complete Guide for US, UK and EU Regulated Companies

For further guidance, refer to the FDA’s Quality System Regulation and the ISO 13485 standard for medical devices, which provide comprehensive insights into establishing and maintaining a compliant QMS.